These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2968333)

  • 1. Current concepts in the treatment of staphylococcal meningitis.
    Quintiliani R; Cooper BW
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():107-14. PubMed ID: 2968333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mannitol on the penetration of teicoplanin into infected CSF of experimental Staphylococcus aureus meningitis of rabbits.
    Manquat G; Stahl JP; Pelloux I; Micoud M
    Infection; 1990; 18(2):113-6. PubMed ID: 2139637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infections of the cerebrospinal fluid shunt].
    Menardi G
    Padiatr Padol; 1989; 24(1):43-8. PubMed ID: 2717191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases.
    Gombert ME; Landesman SH; Corrado ML; Stein SC; Melvin ET; Cummings M
    J Neurosurg; 1981 Oct; 55(4):633-6. PubMed ID: 7277012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
    Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    Klastersky J; Van der Auwera P
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin in infections caused by methicillin-resistant staphylococci.
    Drabu YJ; Walsh B; Blakemore PH; Mehtar S
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():89-92. PubMed ID: 2965136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vancomycin, what else?].
    Daurel C; Leclercq R
    Arch Pediatr; 2010 Sep; 17 Suppl 4():S121-8. PubMed ID: 20826319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
    Strausbaugh LJ; Murray TW; Sande MA
    J Antimicrob Chemother; 1980 May; 6(3):363-71. PubMed ID: 7400069
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care-Associated Meningitis?
    Mounier R; Lobo D; Hulin A; Nebbad B; Cook F; Dhonneur G
    World Neurosurg; 2017 Mar; 99():812.e1-812.e5. PubMed ID: 28034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
    Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF
    J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrocephalus shunt infections and their treatment.
    Andrew JH; Waters MJ
    J Antimicrob Chemother; 1986 Jul; 18(1):145-6. PubMed ID: 3759724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.